Weavely
VUB

Weavely

Software
Software
Software
Software

Weavely helps companies test and validate digital products before launch.

Weavely is a Brussels-based start-up that is building the next generation of tooling for interactive digital content (e.g. Web forms, fillable PDFs, interactive e-mails, etc.). Creators of digital content (i.e. designers, marketeers, sales people) struggle to create appealing and converting content. On the one hand they can opt for standardised solutions (e.g. Google Forms, Typeform, etc.) which are easy to use but fail to produce genuinely bespoke content. On the other hand they can opt to manually create or implement their content, which is very time consuming.

Weavely solves this issue by combining the best of both worlds: a “free-hand” graphical editor that automatically generates interactive digital content from bespoke designs. It does this by combining proprietary design-to-code algorithms and off-the-shelve AI models.

Weavely is a spin-off from the Software Languages Lab of the VUB and results from years of research into no-code programming technology for distributed systems. “While we originally focused on citizen science, the founding team researched crucial aspects of the platform in parallel before finally spinning-off the technology and refocusing its application domain after finishing our PhDs”, says Jesse Zaman, CTO and co-founder of Weavely.

No items found.

Florian Myter, CEO and co-founder: “Weavely currently focuses on the creation of digital forms, but going forward we aim to more broadly revolutionize interactive content creation by also generating fillable PDFs, interactive e-mails and much more”.

Cédric Van Nevel

Cédric Van Nevel

Partner Qbic II & III, Co-founder Qbic III

This company is aligned with the following SDGs

Decent work and economic growth
Decent work and economic growth
Industry, innovation and infrastructure
Industry, innovation and infrastructure
Abscint
Qbic II
Biotech
Biotech
Biotech
Biotech

Abscint

ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.

VUB
UZ Brussel
Aloxy
Qbic II
Software
Software
Software
Software

Aloxy

Aloxy’s Internet of Things technology is enabling the petrochemical industry to innovate.

Universiteit Antwerpen
imec
Axithra
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Axithra

Axithra is developing new technology for accurate drug concentrations in blood.

Universiteit Gent
imec